Should CYP2C19 genotype testing be performed in patients presenting with ISR on Plavix?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Do you recommend against use of enteric coated aspirin as opposed to plain aspirin for secondary prevention of stroke or MI?

Do you continue beta-blocker therapy beyond 1 year after myocardial infarction in a stable patient with normal LV systolic function when the only remaining indication is mildly elevated blood pressure that could be managed with an alternative agent?

Do you add a second antihypertensive agent rather than uptitrating monotherapy in a patient with stage 1 hypertension and suboptimal blood pressure control given evidence that combination regimens are better tolerated than monotherapy?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Events
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.